We are live on ! Find out more
OTIC

Otonomy, Inc.
OTIC

Delisted

OTIC was delisted on the 22nd of December, 2022.

Back to rankings

58 hedge funds and large institutions have $51.9M invested in Otonomy, Inc. in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

279% more call options, than puts

Call options by funds: $1.2M | Put options by funds: $318K

16% less funds holding

Funds holding: 69 → 58 (-11)

33% less capital invested

Capital invested by funds: $77M → $51.9M (-$25.2M)

41% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 27

65% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 17

Holders
58
Holders Change
-11
Holders Change %
-15.94%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
16
Reduced
27
Closed
17
Calls
$1.2M
Puts
$318K
Net Calls
+$886K
Net Calls Change
+$640K

Top Buyers

Rank Fund Capital Flow
1
PVI
Pura Vida Investments
New York
+$657K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$364K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$330K
4
Renaissance Technologies
Renaissance Technologies
New York
+$272K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$256K

Top Sellers

Rank Fund Capital Flow
1
CM
Crestline Management
Texas
-$1.15M
2
Goldman Sachs
Goldman Sachs
New York
-$665K
3
Deutsche Bank
Deutsche Bank
Germany
-$598K
4
Millennium Management
Millennium Management
New York
-$583K
5
PP
Paloma Partners
Connecticut
-$529K

OTIC Hedge Fund Activity: Q3 2018 in Review

58 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Otonomy, Inc. (OTIC) for Q3 2018, worth a combined $51.9M — down 33% from $77M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of OTIC and 6 opened new positions — a net loss of 11 holders — while 27 trimmed existing stakes and 16 added.

The largest buyer was Pura Vida Investments, adding an estimated $657K. The largest seller was Crestline Management, exiting entirely with an estimated $1.15M sold.

  • 58 institutional investors held Otonomy, Inc. (OTIC) as of Q3 2018, down from 69 in Q2 2018.
  • Funds reported $51.9M of Otonomy, Inc. stock for Q3 2018, down 33% quarter-over-quarter.
  • 6 funds opened new Otonomy, Inc. positions in Q3 2018 and 17 closed out, a net change of -11 holders.
  • The largest Otonomy, Inc. buyer in Q3 2018 was Pura Vida Investments, an estimated $657K added.
  • The largest Otonomy, Inc. seller in Q3 2018 was Crestline Management, an estimated $1.15M sold.

Based on aggregated 13F filings for Q3 2018.